Abstract 3151: T cells engineered to express a chimeric antigen receptor targeting chondroitin sulfate proteoglycan 4 (CSPG4) specifically kill medulloblastoma and produce inflammatory cytokines
Christopher M. Rota
◽
Nicholas Tschernia
◽
Steven Feldman
◽
Crystal Mackall
◽
Daniel W. Lee